What HOSPIRA INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Endicott David J. | Pres., Hospira Medical Devices | Sep 03 | Disposition to Issuer · D | −205,668 | $90.00 | −$18.5M | 0 |
| Endicott David J. | Pres., Hospira Medical Devices | Sep 03 | Exercise / conversion · M | +72,971 | $43.01 | +$3.14M | 205,668 |
| Endicott David J. | Pres., Hospira Medical Devices | Sep 03 | Grant / award · A | +15,196 | — | — | 132,697 |
| Yoskowitz Marc J | SVP, Strategy & Corporate Dev | Sep 03 | Disposition to Issuer · D | −110,813 | $90.00 | −$9.97M | 0 |
| Yoskowitz Marc J | SVP, Strategy & Corporate Dev | Sep 03 | Exercise / conversion · M | +28,889 | $42.70 | +$1.23M | 110,813 |
| Yoskowitz Marc J | SVP, Strategy & Corporate Dev | Sep 03 | Exercise / conversion · M | +34,570 | $37.36 | +$1.29M | 81,924 |
| Yoskowitz Marc J | SVP, Strategy & Corporate Dev | Sep 03 | Grant / award · A | +3,640 | — | — | 47,354 |
| Fenton Dennis M | Director | Sep 03 | Disposition to Issuer · D | −15,477 | $90.00 | −$1.39M | 0 |
| Bailey Irving W Ii | Director | Sep 03 | Disposition to Issuer · D | −15,000 | $90.00 | −$1.35M | 0 |
| Bailey Irving W Ii | Director | Sep 03 | Disposition to Issuer · D | −40,785 | $90.00 | −$3.67M | 0 |
| Stober Matthew R | SVP, Operations | Sep 03 | Disposition to Issuer · D | −166,401 | $90.00 | −$15M | 0 |
| Stober Matthew R | SVP, Operations | Sep 03 | Exercise / conversion · M | +33,333 | $42.70 | +$1.42M | 166,401 |
| Stober Matthew R | SVP, Operations | Sep 03 | Exercise / conversion · M | +28,457 | $28.95 | +$824K | 133,068 |
| Stober Matthew R | SVP, Operations | Sep 03 | Exercise / conversion · M | +4,990 | $35.36 | +$176K | 104,611 |
| Stober Matthew R | SVP, Operations | Sep 03 | Grant / award · A | +12,066 | — | — | 99,621 |
| Stober Matthew R | SVP, Operations | Sep 03 | Grant / award · A | +9,173 | — | — | 87,555 |
| Stober Matthew R | SVP, Operations | Sep 03 | Grant / award · A | +15,744 | — | — | 78,382 |
| Stober Matthew R | SVP, Operations | Sep 03 | Disposition to Issuer · D | −2,323 | $90.00 | −$209K | 0 |
| Stober Matthew R | SVP, Operations | Sep 03 | Exercise / conversion · M | +2,323 | — | — | 2,323 |
| Dempsey William G | Director | Sep 03 | Disposition to Issuer · D | −20,383 | $90.00 | −$1.83M | 0 |
Loading...
